Clinical trial
Improving Followup of Abnormal Colon Cancer Screening Tests
NCT00436137 · Harvard Vanguard Medical Associates, Other · Completed
Key facts
| NCT number | NCT00436137 |
|---|---|
| Title | Improving Followup of Abnormal Colon Cancer Screening Tests |
| Official title | Improving Followup of Positive Fecal Occult Blood Tests |
| Lead sponsor | Harvard Vanguard Medical Associates, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Behavioral |
| Interventions | Patient mailing |
| Enrollment | 70 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Feb 16, 2007 |
| Last update posted | Nov 6, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: